Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate |
2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2015-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101541383-B1 |
titleOfInvention |
Immunogenic composition |
abstract |
The present invention relates to immunogenic compositions comprising 5-and / or 8-type capsular polysaccharides or oligosaccharides from S. aureus having an O-acetylation rate of 30-100%. Vaccines comprising 5-and / or 8-type capsular polysaccharides or oligosaccharides from S. aureus having an O-acetylation rate of 30-100%, methods of treatment using such immunogenic compositions, and methods of treating such immunogenicity A process for making a composition is also disclosed. |
priorityDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |